Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aldosterone receptor antagonists: effective but often forgotten.

Literature DB >> 20177008

Aldosterone receptor antagonists: effective but often forgotten.

Bradley A Maron¹, Jane A Leopold.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20177008 PMCID： PMC2828634 DOI： 10.1161/CIRCULATIONAHA.109.895235

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

37 in total

1. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.

Authors: Carmine Savoia; Rhian M Touyz; Farhad Amiri; Ernesto L Schiffrin
Journal: Hypertension Date: 2008-01-14 Impact factor: 10.190

Review 2. A comparison of the aldosterone-blocking agents eplerenone and spironolactone.

Authors: Allan Struthers; Henry Krum; Gordon H Williams
Journal: Clin Cardiol Date: 2008-04 Impact factor: 2.882

3. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.

Authors: Jane A Leopold; Aamir Dam; Bradley A Maron; Anne W Scribner; Ronglih Liao; Diane E Handy; Robert C Stanton; Bertram Pitt; Joseph Loscalzo
Journal: Nat Med Date: 2007-02-04 Impact factor: 53.440

4. Effect of spironolactone on blood pressure in subjects with resistant hypertension.

Authors: Neil Chapman; Joanna Dobson; Sarah Wilson; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Journal: Hypertension Date: 2007-02-19 Impact factor: 10.190

5. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors: Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal: J Am Coll Cardiol Date: 2006-11-13 Impact factor: 24.094

6. Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.

Authors: Alessandro Boccanelli; Gian Francesco Mureddu; Giuseppe Cacciatore; Francesco Clemenza; Andrea Di Lenarda; Antonello Gavazzi; Maurizio Porcu; Roberto Latini; Donata Lucci; Aldo Pietro Maggioni; Serge Masson; Massimo Vanasia; Giovanni de Simone
Journal: Eur J Heart Fail Date: 2009-01 Impact factor: 15.534

7. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

Authors: Bertram Pitt; George Bakris; Luis M Ruilope; Lorenzo DiCarlo; Robin Mukherjee
Journal: Circulation Date: 2008-09-29 Impact factor: 29.690

8. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.

Authors: Cristiana Catena; GianLuca Colussi; Roberta Lapenna; Elisa Nadalini; Alessandra Chiuch; Pasquale Gianfagna; Leonardo A Sechi
Journal: Hypertension Date: 2007-09-24 Impact factor: 10.190

9. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.

Authors: Asterios Karagiannis; Konstantinos Tziomalos; Athanasios Papageorgiou; Anna I Kakafika; Efstathios D Pagourelias; Panagiotis Anagnostis; Vasilios G Athyros; Dimitri P Mikhailidis
Journal: Expert Opin Pharmacother Date: 2008-03 Impact factor: 3.889

Review 10. Resistant hypertension: an overview of evaluation and treatment.

Authors: Pantelis A Sarafidis; George L Bakris
Journal: J Am Coll Cardiol Date: 2008-11-25 Impact factor: 24.094

24 in total

1. Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction.

Authors: Kun Liu; Liang Shao; Li Wang; Yanping Ding; Guanhua Su; Jue Wang; Yuhua Liao; Zhaohui Wang
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2010-11-10

Review 2. Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.

Authors: Sohita Dhillon
Journal: Drugs Date: 2013-09 Impact factor: 9.546

Review 3. Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications.

Authors: Mindy Markowitz; Frank Messineo; Neil L Coplan
Journal: Clin Cardiol Date: 2012-07-06 Impact factor: 2.882

Review 4. S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system.

Authors: Bradley A Maron; Shiow-Shih Tang; Joseph Loscalzo
Journal: Antioxid Redox Signal Date: 2012-09-05 Impact factor: 8.401

5. Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

Authors: Eve Maubec; Cédric Laouénan; Lydia Deschamps; Van Tuan Nguyen; Isabelle Scheer-Senyarich; Anne-Catherine Wackenheim-Jacobs; Maud Steff; Stéphanie Duhamel; Sarah Tubiana; Nesrine Brahimi; Stéphanie Leclerc-Mercier; Béatrice Crickx; Claudine Perret; Selim Aractingi; Brigitte Escoubet; Xavier Duval; Philippe Arnaud; Frederic Jaisser; France Mentré; Nicolette Farman
Journal: J Invest Dermatol Date: 2015-02-10 Impact factor: 8.551

Review 10. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors: Bradley A Maron; Jane A Leopold
Journal: Pulm Circ Date: 2014-06 Impact factor: 3.017